Sun, March 9, 2025
Sat, March 8, 2025
[ Sat, Mar 08th ] - CNBC
The Look Ahead: March 7, 2025
Fri, March 7, 2025
Thu, March 6, 2025
Wed, March 5, 2025
Tue, March 4, 2025
Mon, March 3, 2025
Sun, March 2, 2025

Prenetics Announces Fourth Quarter and Full Year 2024 Financial Results, Provides 2025 Guidance


//business-finance.news-articles.net/content/202 .. 24-financial-results-provides-2025-guidance.html
Published in Business and Finance on by manilatimes   Print publication without navigation

CHARLOTTE, N.C., March 05, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading health sciences company, today announced its preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2024, along with recent business updates.

Prenetics, a leading genomics-driven health sciences company, announced its financial results for the fourth quarter and full year of 2024, along with providing guidance for 2025. The company reported a significant increase in revenue, driven by the expansion of its consumer genetics and clinical testing services. For the full year, Prenetics achieved a revenue growth of 35% compared to the previous year, with a notable performance in its core markets of Hong Kong and the UK. The company also highlighted advancements in its research and development, particularly in the areas of oncology and infectious diseases, which are expected to contribute to future growth. Looking ahead to 2025, Prenetics provided optimistic guidance, expecting continued revenue growth and profitability, supported by new product launches, strategic partnerships, and market expansion into new regions. The company also emphasized its commitment to leveraging AI and big data to enhance its diagnostic capabilities and personalized health solutions.

Read the Full manilatimes Article at:
[ https://www.manilatimes.net/2025/03/05/tmt-newswire/globenewswire/prenetics-announces-fourth-quarter-and-full-year-2024-financial-results-provides-2025-guidance/2067814 ]

Publication Contributing Sources